1 |
Alexius-Lindgren M, Andersson E, Lindstedt I, et al (2014). The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases. Anticancer Res, 34, 3867-73.
|
2 |
Cho YB, Lee WY, Song SY, et al (2007). Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer. Hum Pathol, 38, 1603-10.
DOI
|
3 |
Clark JC, Thomas DM, Choong PF, et al (2007). RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev, 26, 675-83.
DOI
|
4 |
Furumoto K, Arii S, Mori A, et al (2001). RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs. Hepatology, 33, 189-95.
DOI
|
5 |
Jeon HW, Lee YM (2010). Inhibition of histone deacetylase attenuates hypoxia-induced migration andinvasion of cancer cells via the restoration of RECK expression. Mol Cancer Ther, 9, 1361-70.
DOI
|
6 |
Khaderi S, Guiteau J, Cotton RT, et al (2014). Role of liver transplantation in the management of hepatoblastoma in the pediatric population. World J Transplant, 4, 294-8.
DOI
|
7 |
Kimura T, Okada A, Yatabe T, et al (2010). RECK is up-regulated and involved in chondrocyte cloning in humanosteoarthritic cartilage. Am J Pathol, 176, 2858-67.
DOI
|
8 |
Kremer N, Walther AE, Tiao GM (2014). Management of hepatoblastoma: an update. Curr Opin Pediatr, 26, 362-9.
DOI
|
9 |
Martinez-Criado Y, Cabello R, Fernandez-Pineda I, et al (2013). Study of the expression of neural stem cell markers in neuroblastoma tumor samples and correlation with prognostic factors. Cir Pediatr, 26, 112-8.
|
10 |
Morandi F, Corrias MV, Pistoia V (2015). Evaluation of bone marrow as a metastatic site of human neuroblastoma. Ann N Y Acad Sci, 1335, 23-31.
DOI
|
11 |
Peters H, Augusto TM, Bruni-Cardoso A, et al (2010). RECK expression in the rat ventral prostate: response to castration involves a balance between epithelial and stromal expression. Anat Rec (Hoboken), 293, 993-7.
DOI
|
12 |
Verma S, Kesh K, Ganguly N, et al (2014). Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants. World J Biol Chem, 5, 355-76.
DOI
|
13 |
Wang JL, Wu DW, Cheng ZZ, et al (2014). Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC). Asian Pac J Cancer Prev, 15, 4865-9.
DOI
|
14 |
Xie J, Tan ZH, Tang X, et al (2014). MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. World J Gastroenterol, 20, 17439-47.
DOI
|
15 |
Yanez Y, Grau E, Rodriguez-Cortez VC, et al (2015). Two independent epigenetic biomarkers predict survival in neuroblastoma. Clin Epigenetics, 7, 16.
DOI
|
16 |
Yang L, Li N, Wang S, et al (2014). Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 15, 4823-7.
DOI
|
17 |
Zhang Y, Zhang WL, Huang DS, et al (2013). Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study. Asian Pac J Cancer Prev, 14, 4583-9.
DOI
ScienceOn
|